16-89918814-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000555427.1(MC1R):​c.-408-37G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 238,202 control chromosomes in the GnomAD database, including 15,897 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9608 hom., cov: 33)
Exomes 𝑓: 0.33 ( 6289 hom. )

Consequence

MC1R
ENST00000555427.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.78

Publications

13 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 16-89918814-G-A is Benign according to our data. Variant chr16-89918814-G-A is described in ClinVar as Benign. ClinVar VariationId is 321404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.627 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1213-37G>A intron_variant Intron 3 of 3 XP_047290987.1
MC1RNM_002386.4 linkc.-445G>A upstream_gene_variant ENST00000555147.2 NP_002377.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555427.1 linkc.-408-37G>A intron_variant Intron 2 of 3 5 ENSP00000451760.1
MC1RENST00000639847.1 linkc.-408-37G>A intron_variant Intron 2 of 2 5 ENSP00000492011.1
MC1RENST00000555147.2 linkc.-445G>A upstream_gene_variant 6 NM_002386.4 ENSP00000451605.1

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51779
AN:
152092
Hom.:
9589
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.401
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.413
Gnomad ASJ
AF:
0.243
Gnomad EAS
AF:
0.646
Gnomad SAS
AF:
0.459
Gnomad FIN
AF:
0.411
Gnomad MID
AF:
0.296
Gnomad NFE
AF:
0.252
Gnomad OTH
AF:
0.306
GnomAD4 exome
AF:
0.332
AC:
28576
AN:
85992
Hom.:
6289
Cov.:
0
AF XY:
0.332
AC XY:
13245
AN XY:
39844
show subpopulations
African (AFR)
AF:
0.391
AC:
1525
AN:
3896
American (AMR)
AF:
0.454
AC:
1688
AN:
3720
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
1252
AN:
5142
East Asian (EAS)
AF:
0.782
AC:
8933
AN:
11424
South Asian (SAS)
AF:
0.445
AC:
453
AN:
1018
European-Finnish (FIN)
AF:
0.368
AC:
53
AN:
144
Middle Eastern (MID)
AF:
0.293
AC:
144
AN:
492
European-Non Finnish (NFE)
AF:
0.236
AC:
12589
AN:
53252
Other (OTH)
AF:
0.281
AC:
1939
AN:
6904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
792
1584
2375
3167
3959
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.341
AC:
51838
AN:
152210
Hom.:
9608
Cov.:
33
AF XY:
0.354
AC XY:
26323
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.402
AC:
16683
AN:
41538
American (AMR)
AF:
0.414
AC:
6330
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
842
AN:
3468
East Asian (EAS)
AF:
0.645
AC:
3338
AN:
5172
South Asian (SAS)
AF:
0.457
AC:
2204
AN:
4824
European-Finnish (FIN)
AF:
0.411
AC:
4358
AN:
10610
Middle Eastern (MID)
AF:
0.291
AC:
85
AN:
292
European-Non Finnish (NFE)
AF:
0.252
AC:
17123
AN:
67978
Other (OTH)
AF:
0.309
AC:
653
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1727
3455
5182
6910
8637
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.284
Hom.:
25728
Bravo
AF:
0.345
Asia WGS
AF:
0.506
AC:
1762
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
7.2
DANN
Benign
0.94
PhyloP100
1.8
PromoterAI
-0.057
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212361; hg19: chr16-89985222; COSMIC: COSV59624822; COSMIC: COSV59624822; API